AJP - Endocrinology and Metabolism, Vol 271, Issue 4 E725-E732, Copyright © 1996 by American Physiological Society

ARTICLES

Decreased glucose-induced cAMP and insulin release in islets of diabetic rats: reversal by IBMX, glucagon, GIP

N. Dachicourt, P. Serradas, M. H. Giroix, M. N. Gangnerau and B. Portha
Laboratoire de Physiopathologie de la Nutrition Centre National de la Recherche Scientifique, Unite de Recherche Associee 307, Universite Paris 7, France.

The first aim of the study was to investigate the possibility that a defect on the islet adenosine 3',5'-cyclic monophosphate (cAMP) production could be involved in the failure of the glucose-induced insulin secretion in the neonatal streptozotocin diabetic rats. Exposure to glucose concentration that induced a rise of the cAMP content in the control islets did not elicit any significant increase in cAMP in diabetic islets. Forskolin, isobutyl methylxanthine (IBMX), glucagon, or pertussis toxin amplified the cAMP accumulation and the insulin release to the same extent in both types of islets. Somatostatin, prostaglandin E2, UK-14304, or galanin inhibited cAMP accumulation and insulin release to the same extent in both types of islets. Our second purpose was to investigate whether the use of activators of adenylate cyclase could restore the beta-cell competence to glucose in diabetic rats. The addition of IBMX, glucagon, or gastric inhibitory polypeptide (GIP) to perifused islets of diabetic rats amplified their insulin response to glucose, and a clear biphasic pattern of the release was regained. In conclusion, although there is no major alteration of the functionality of the adenylate cyclase in the beta-cells of the diabetic rats, we have identified a defective glucose-induced cAMP generation that could be explained by a block in the step(s) linking glucose metabolism and activation of adenylate cyclase.

This article has been cited by other articles:

				J. A. Pospisilik, J. Martin, T. Doty, J. A. Ehses, N. Pamir, F. C. Lynn, S. Piteau, H.-U. Demuth, C. H.S. McIntosh, and R. A. Pederson Dipeptidyl Peptidase IV Inhibitor Treatment Stimulates {beta}-Cell Survival and Islet Neogenesis in Streptozotocin-Induced Diabetic Rats Diabetes, March 1, 2003; 52(3): 741 - 750. [Abstract] [Full Text] [PDF]

				H. Kasai, T. Suzuki, T.-T. Liu, T. Kishimoto, and N. Takahashi Fast and cAMP-Sensitive Mode of Ca2+-Dependent Exocytosis in Pancreatic {beta}-Cells Diabetes, February 1, 2002; 51(90001): S19 - 24. [Abstract] [Full Text] [PDF]

				T. Niwa, Y. Nimura, and I. Niki Lack of effect of incretin hormones on insulin release from pancreatic islets in the bile duct-ligated rats Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E59 - E64. [Abstract] [Full Text] [PDF]

				A. Astesano, K. Regnauld, N. Ferrand, D. Gingras, M. Bendayan, G. Rosselin, and S. Emami Cellular and Subcellular Expression of Golf/Gs and Gq/G11 {alpha}-Subunits in Rat Pancreatic Endocrine Cells J. Histochem. Cytochem., March 1, 1999; 47(3): 289 - 302. [Abstract] [Full Text]

				N. Takahashi, T. Kadowaki, Y. Yazaki, G. C. R. Ellis-Davies, Y. Miyashita, and H. Kasai Post-priming actions of ATP on Ca2+-dependent exocytosis in pancreatic beta cells PNAS, January 19, 1999; 96(2): 760 - 765. [Abstract] [Full Text] [PDF]